Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

被引：42
|
作者：
Brown, Kelly A. [1 ]
Samuel, Sharmeen [1 ]
Patel, Dilip R. [1 ]
机构：
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
来源：
TRANSLATIONAL PEDIATRICS | 2018年 / 7卷 / 01期
关键词：
Attention-deficit/hyperactivity disorder (ADHD); stimulants; non-stimulant medication; methylphenidate; amphetamine; alpha-2-agonists; DEFICIT/HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; STIMULANT-DRUGS; UNITED-STATES; ADHD DRUGS; ATOMOXETINE; METHYLPHENIDATE; SAFETY; PHARMACOTHERAPY; RELEASE;
D O I：
10.21037/tp.2017.08.02
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
引用
收藏
页码：36 / 47
页数：12
相关论文
共 50 条
  • [41] PSYCHOTROPIC POLYPHARMACY IN CHILDREN AND ADOLESCENTS WITH ATTENTION - DEFICIT/HYPERACTIVITY DISORDER
    Palli, S. R.
    Aparasu, R. R.
    Chen, H.
    Sherer, J. T.
    VALUE IN HEALTH, 2011, 14 (03) : A200 - A200
  • [42] Atomoxetine therapy for children and adolescents with attention deficit hyperactivity disorder
    Jeffrey H. Newcorn
    Current Psychiatry Reports, 2003, 5 (2) : 85 - 85
  • [43] Efficacy of Strattera in children and adolescents with attention deficit hyperactivity disorder
    Vakula I.N.
    Vasyanina Yu.Sh.
    Gorbunova Z.Kh.
    Nikiforova E.Yu.
    Ponomarenko E.I.
    Neuroscience and Behavioral Physiology, 2010, 40 (9) : 1034 - 1037
  • [44] Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents
    Bjornstad, G
    Montgomery, P
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [45] Families of children with attention deficit hyperactivity disorder: A review
    Hechtman, L
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1996, 41 (06): : 350 - 360
  • [46] Evaluation and Management of Elevated Blood Pressure in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Ikuyo Yamaguchi
    Coral Hanevold
    Current Hypertension Reports, 2019, 21
  • [47] Evaluation and Management of Elevated Blood Pressure in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Yamaguchi, Ikuyo
    Hanevold, Coral
    CURRENT HYPERTENSION REPORTS, 2019, 21 (08)
  • [48] Systematic Review: Educational Accommodations for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Lovett, Benjamin J.
    Nelson, Jason M.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (04): : 448 - 457
  • [49] Emotional scene processing in children and adolescents with attention deficit/hyperactivity disorder: a systematic review
    Anaïs Leroy
    Sara Spotorno
    Sylvane Faure
    European Child & Adolescent Psychiatry, 2021, 30 : 331 - 346
  • [50] Atomoxetine: A review of its use in attention-deficit hyperactivity disorder in children and adolescents
    Garnock-Jones K.P.
    Keating G.M.
    Pediatric Drugs, 2009, 11 (3) : 203 - 226
12345